Relative Strength Chart Prestige Biologics Co., Ltd.

Equities

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/06/2024 am IST			5-day change	1st Jan Change
4,200 ^KRW	-4.55%		-5.51%	-4.55%

2023	Prestige Biologics Co., Ltd. announced that it has received KRW 45.5 billion in funding from Octava Fund Limited	CI
2023	Prestige Biologics Co., Ltd. announced that it expects to receive KRW 45.5 billion in funding from Octava Fund Limited	CI

End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	PRESTIGE BIOLOGICS CO., LTD.	Biopharmaceuticals	-4.55%	-5.51%	-4.55%	-18.13%	-	187M